News Briefs Wellcome Backs Lectus By PE Hub Staff - 6 September 2007 Share A- A+ 100% Lectus Therapeutics Ltd., a Cambridge, UK-based drug company focused on ion channel modulators, has raised Gbp3 million from the Wellcome Trust. www.lectustherapeutics.com Share this:TwitterLinkedIn